Progressive restrictive cardiomyopathy. A case report.

Iga, Kanji; Kitaguchi, Shouji; Hori, Kenjiro; Matsumura, Tadashi; Tomonaga, Go; Gen, Hiromitu; Tamamura, Toshitake

doi:10.1253/jcj.55.699

Jpn Circ J

1991

DOI: 10.1253/jcj.55.699

|View full text |Cite

Progressive restrictive cardiomyopathy. A case report.

Kanji Iga¹,

Shouji Kitaguchi²,

Kenjiro Hori³

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2019

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A decreased left ventricular ejection fraction (LVEF) was observed in patients suffering from septic shock with normalization of systolic function after 10 days [31]. Similar courses of reversible myocardial dysfunction due to the systemic inflammatory response syndrome were also found in other critical illnesses [32][33][34].…”

mentioning

confidence: 83%

The Role of BCL2 Protein and Tumour Protein p53 in Septic Cardiomyopathy

Reil¹,

Maghiar²,

Seidl³

et al. 2019

Rev.Chim.

View full text Add to dashboard Cite

A decreased left ventricular ejection fraction (LVEF) was observed in patients suffering from septic shock with normalization of systolic function after 10 days.�Similar courses of reversible myocardial dysfunction due to the systemic inflammatory response syndrome were also encountered in other critical illnesses. Since the pathological and histological mechanisms are not fully understood, the present study tries to understand the septic cardiomyopathy related to the apoptotic pathway. Thestudy included a number of 29�cases of adults that died of septic shock being analysed for BCL2 and p53 expression rates of myocardial tissue. This is the first time the expression of BCL2 protein, p53 tumour protein were evaluated in septic shock and septic cardiomyopathy of humans.�There was a strong link between the increased expression of BCL2 and of p53 protein in cardiac muscle cells in the studied group (p=0.0300).�The study showed a significant correlation between markedly increased values and poor outcome.

show abstract

mentioning

confidence: 83%

The Role of BCL2 Protein and Tumour Protein p53 in Septic Cardiomyopathy

Reil¹,

Maghiar²,

Seidl³

et al. 2019

Rev.Chim.

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Progressive restrictive cardiomyopathy. A case report.

Cited by 1 publication

References 0 publications

The Role of BCL2 Protein and Tumour Protein p53 in Septic Cardiomyopathy

The Role of BCL2 Protein and Tumour Protein p53 in Septic Cardiomyopathy

Contact Info

Product

Resources

About